Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Offerings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Media
  • News
  • Offerings
  • Tech

WISeKey International To Raise Debt Via Convertible Note Sales To Institutional Investors

By Anusuya Lahiri
Today, 6:48 AM
WISeKey International Holding Ltd (NASDAQ:WKEY) inked a convertible notes subscription agreement of up to $44 million and warrant agreement with institutional…

WKEY

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • IPOs
  • News
  • Offerings

Gilead, Foresite Take Pardes Biosciences Public In $250M SPAC Deal

By Vandana Singh
Today, 6:48 AM
Pardes Biosciences Inc, an early-stage biopharmaceutical company, and FS Development Corp. II (NASDAQ:FSII), a Foresite Capital sponsored SPAC, entered into a…

FSII

Read More
1 minute read
  • News
  • Offerings
  • Penny Stocks

Better Choice Raises $40M Via Equity At 32% Discount

By Shivani Kumaresan
Today, 6:48 AM
Better Choice Company Inc (NYSE:BTTR) has priced 8 million shares of common stock at $5.0 per share in a secondary public…

BTTR

Read More
1 minute read
  • Bonds
  • Markets
  • News
  • Offerings
  • Rumors

Salesforce To Sell $8B In Bonds Via 6-Part Deal

By Benzinga Newsdesk
Today, 6:48 AM
-Bloomberg

CRM

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • News
  • Offerings

Kymera Therapeutics Seeks To Raise Capital Via 4M Shares Equity Offering To Fund Oncology Franchises

By Vandana Singh
Today, 6:48 AM
Kymera Therapeutics Inc (NASDAQ:KYMR) commenced an underwritten public offering of 4 million shares of common stock.  Underwriters can purchase up to…

KYMR

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • News
  • Offerings
  • Small Cap

Aligos Therapeutics Presses Capital Raise Button

By Vandana Singh
Today, 6:48 AM
Aligos Therapeutics Inc (NASDAQ:ALGS) commenced an underwritten public offering of 4 million shares of common stock.  Underwriters can purchase up to…

ALGS

Read More
5 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • News
  • Offerings
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout

By Shanthi Rexaline
Today, 6:48 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28)

ABUS

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • News
  • Offerings

Intellia Seeks To Raise $400M Via Equity

By Vandana Singh
Today, 6:48 AM
Intellia Therapeutics Inc (NASDAQ:NTLA) commenced an underwritten public offering of $400 million shares of its common stock.  Underwriters have an option…

NTLA

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • News
  • Offerings

Zentalis Secures $150M In Equity Funding

By Vandana Singh
Today, 6:48 AM
Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) priced an underwritten public offering of 3.1 million shares at $48.50 per share, for gross proceeds of…

ZNTL

Read More
1 minute read
  • News
  • Offerings

Proterra Inc Files For Offer And Sale Of Up To 168.72M Shares Of Common Stock By Selling Securityholders

By Bill Haddad
Today, 6:48 AM
-Reuters

PTRA

Posts navigation

Previous 1 … 166 167 168 … 178 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service